Trials / Conditions / Pre-Exposure Prophylaxis of HIV Infection
Pre-Exposure Prophylaxis of HIV Infection
6 registered clinical trials studyying Pre-Exposure Prophylaxis of HIV Infection — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Evaluating the Healthy Families PrEP Program for Women at Risk for HIV NCT06746675 | Yale University | N/A |
| Active Not Recruiting | Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP) NCT06513312 | Gilead Sciences | Phase 2 |
| Active Not Recruiting | Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People W NCT06101342 | Gilead Sciences | Phase 2 |
| Active Not Recruiting | Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender NCT06101329 | Gilead Sciences | Phase 2 |
| Active Not Recruiting | Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and NCT04994509 | Gilead Sciences | Phase 3 |
| Active Not Recruiting | Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection NCT04925752 | Gilead Sciences | Phase 3 |